Signe Fransen

Signe Fransen has a diverse work experience in the biotechnology and pharmaceutical industry. Signe is currently serving as the Vice President of Clinical and Medical Affairs at Strata Oncology since May 2023. Prior to that, they worked as a Scientific & Medical Affairs Consultant at Signe Fransen Consulting from December 2021 to May 2023. Signe also held the position of Vice President of Scientific & Medical Affairs at Salish Bioscience Inc. from January 2022 to March 2023.

Before their consulting role, Signe Fransen worked at Freenome as the Senior Director of Scientific & Medical Affairs from March 2018 to November 2021. In addition, they gained significant experience during their tenure at Bristol-Myers Squibb, where they held various roles including Immuno-Oncology Biomarkers and Diagnostics Medical Scientist from January 2017 to April 2018, Worldwide Associate Medical Director for HIV from October 2015 to May 2017, Executive Virology Medical Science Liaison from April 2015 to September 2015, Senior Medical Science Liaison from October 2012 to April 2015, and Medical Science Liaison from an unknown start date to October 2012.

Signe Fransen initiated their career as a Scientist in R&D at Monogram Biosciences in January 2001, where they worked until June 2010.

Signe Fransen obtained a Master of Science (M.Sc.) degree in Microbiology and Immunology from 1997 to 1999. The specific university attended during this period is not mentioned.